학술논문
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors
Document Type
Article
Author
Source
In: Clinical and Translational Oncology . (Clinical and Translational Oncology, February 2024, 26(2):532-537)
Subject
Language
English
ISSN
16993055
1699048X
1699048X